Theraclion SA(TCLIF)
$0.530.00 (0.00%)
TCLIF
Theraclion SA financials statements
$0.53
At close:0.00 (0.00%)
Theraclion SA (TCLIF) Ratios
4 Followers
Theraclion SA Ratios
TCLIF's free cash flow for Q2 2026 was €0.00. For the 2026 fiscal year, TCLIF's free cash flow was increased by €0.00 and operating cash flow was €0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.21 | 2.21 | 2.39 | 2.40 | 2.48 |
| Quick Ratio | 1.49 | 1.64 | 1.94 | 1.62 | 1.65 |
| Cash Ratio | 0.45 | 1.11 | 1.16 | 0.64 | 0.77 |
| Solvency Ratio | -0.35 | -0.43 | -0.27 | -0.36 | -0.28 |
| Operating Cash Flow Ratio | -1.70 | -0.78 | -0.37 | -1.35 | -1.21 |
| Short-Term Operating Cash Flow Coverage | -14.18 | 0.00 | 0.00 | -3.28 | 0.00 |
| Net Current Asset Value | € -5.80M | € -3.19M | € 3.10M | € -4.05M | € -5.16M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.41 | 0.11 | 0.10 | 0.18 | 0.20 |
| Debt-to-Equity Ratio | -1.97 | -11369.81 | 0.35 | 4.61 | -1.88 |
| Debt-to-Capital Ratio | 2.03 | 1.00 | 0.26 | 0.82 | 2.13 |
| Long-Term Debt-to-Capital Ratio | 2.30 | 1.00 | 0.26 | 0.94 | 2.13 |
| Financial Leverage Ratio | -4.83 | -100580.38 | 3.31 | 25.59 | -9.30 |
| Debt Service Coverage Ratio | -7.72 | 0.00 | -109.30 | -2.87 | -25.89 |
| Interest Coverage Ratio | -39.35 | 0.00 | -100.27 | -143.17 | -34.83 |
| Debt to Market Cap | 0.15 | 0.08 | 0.11 | 0.40 | 0.08 |
| Interest Debt Per Share | 0.09 | 0.03 | 0.04 | 0.09 | 0.11 |
| Net Debt to EBITDA | -0.54 | 0.49 | 1.31 | -0.00 | 0.02 |
| Profitability Margins | |||||
| Gross Profit Margin | -523.52% | -865.42% | -59.29% | -246.91% | -306.55% |
| EBIT Margin | -537.44% | -812.05% | -257.53% | -479.32% | -306.21% |
| EBITDA Margin | -504.47% | -712.77% | -246.25% | -464.63% | -297.35% |
| Operating Profit Margin | -537.44% | -838.55% | -173.09% | -510.54% | -319.85% |
| Pretax Profit Margin | -550.34% | -812.15% | -259.25% | -482.89% | -313.50% |
| Net Profit Margin | -479.76% | -693.61% | -201.68% | -401.83% | -253.88% |
| Continuous Operations Profit Margin | -479.76% | -693.63% | -201.68% | -401.83% | -253.88% |
| Net Income Per EBT | 87.18% | 85.41% | 77.79% | 83.21% | 80.98% |
| EBT Per EBIT | 102.40% | 96.85% | 149.78% | 94.58% | 98.02% |
| Return on Assets (ROA) | -45.48% | -50.21% | -19.69% | -35.60% | -31.78% |
| Return on Equity (ROE) | 219.86% | 5050000.00% | -65.08% | -911.12% | 295.44% |
| Return on Capital Employed (ROCE) | -76.75% | -90.16% | -26.42% | -62.75% | -54.93% |
| Return on Invested Capital (ROIC) | -63.07% | -76.99% | -20.55% | -45.02% | -44.48% |
| Return on Tangible Assets | -50.00% | -55.71% | -21.07% | -39.26% | -34.58% |
| Earnings Yield | -16.25% | -37.73% | -20.71% | -18.69% | -12.61% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.43 | 1.86 | 0.51 | 0.34 | 1.20 |
| Payables Turnover | 5.30 | 5.57 | 1.46 | 2.48 | 6.17 |
| Inventory Turnover | 2.44 | 3.79 | 0.95 | 1.40 | 2.28 |
| Fixed Asset Turnover | 1.35 | 0.94 | 17.19 | 9.70 | 32.57 |
| Asset Turnover | 0.09 | 0.07 | 0.10 | 0.09 | 0.13 |
| Working Capital Turnover Ratio | 0.25 | 0.12 | 0.25 | 0.24 | 0.34 |
| Cash Conversion Cycle | 937.09 | 227.07 | 857.46 | 1185.82 | 403.88 |
| Days of Sales Outstanding | 856.49 | 196.42 | 722.70 | 1073.06 | 303.06 |
| Days of Inventory Outstanding | 149.41 | 96.23 | 384.13 | 260.20 | 159.96 |
| Days of Payables Outstanding | 68.80 | 65.58 | 249.37 | 147.44 | 59.14 |
| Operating Cycle | 1005.89 | 292.65 | 1106.83 | 1333.26 | 463.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.12 | -0.06 | -0.05 | -0.18 | -0.17 |
| Free Cash Flow Per Share | -0.12 | -0.07 | -0.06 | -0.19 | -0.18 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -28.54 | -22.13 | -16.32 | -26.20 |
| Capital Expenditure Coverage Ratio | 0.00 | -28.54 | -22.13 | -16.32 | -26.20 |
| Operating Cash Flow Coverage Ratio | -1.41 | -2.25 | -1.27 | -2.10 | -1.62 |
| Operating Cash Flow to Sales Ratio | -6.04 | -3.51 | -1.36 | -4.26 | -2.62 |
| Free Cash Flow Yield | -20.44% | -19.75% | -14.64% | -21.04% | -13.52% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.16 | -2.65 | -4.83 | -5.35 | -7.93 |
| Price-to-Sales (P/S) Ratio | 29.53 | 18.38 | 9.74 | 21.50 | 20.14 |
| Price-to-Book (P/B) Ratio | -13.53 | -133831.06 | 3.14 | 48.76 | -23.44 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.89 | -5.06 | -6.83 | -4.75 | -7.40 |
| Price-to-Operating Cash Flow Ratio | -4.89 | -5.24 | -7.14 | -5.04 | -7.68 |
| Price-to-Earnings Growth (PEG) Ratio | 0.33 | -0.05 | 0.09 | -0.86 | 0.24 |
| Enterprise Value Multiple | -6.39 | -2.09 | -2.65 | -4.63 | -6.76 |
| Enterprise Value | 38.23M | 12.38M | 11.88M | 26.59M | 29.76M |
| EV to EBITDA | -6.39 | -2.09 | -2.65 | -4.63 | -6.76 |
| EV to Sales | 32.24 | 14.92 | 6.52 | 21.52 | 20.09 |
| EV to Free Cash Flow | -5.34 | -4.11 | -4.57 | -4.76 | -7.38 |
| EV to Operating Cash Flow | -5.34 | -4.25 | -4.78 | -5.05 | -7.66 |
| Tangible Book Value Per Share | -0.06 | -0.02 | 0.10 | -0.01 | -0.10 |
| Shareholders’ Equity Per Share | -0.04 | -0.00 | 0.12 | 0.02 | -0.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.13 | 0.15 | 0.22 | 0.17 | 0.19 |
| Revenue Per Share | 0.02 | 0.02 | 0.04 | 0.04 | 0.07 |
| Net Income Per Share | -0.10 | -0.12 | -0.08 | -0.17 | -0.17 |
| Tax Burden | 0.87 | 0.85 | 0.78 | 0.83 | 0.81 |
| Interest Burden | 1.02 | 1.00 | 1.01 | 1.01 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 3.48 | 2.58 |
| SG&A to Revenue | 1.09 | 1.17 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.26 | 0.51 | 0.68 | 1.06 | 1.03 |
Currency in EUR

